Showing results (411-420 of 473) with videos related to
Sort By:
Pageof 48
Environment International|August 3, 2022
Associations between airborne crude oil chemicals and symptom-based asthmaKaitlyn G Lawrence, Nicole M Niehoff, Alexander P Keil, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2019
Lung Lavage Granulocyte Patterns and Clinical Phenotypes in Children with Severe, Therapy-Resistant AsthmaW Gerald Teague, Monica G Lawrence, Debbie-Ann T Shirley, et al.Nature Communications|October 29, 2021
Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineeringKristin J Adolfsen, Isolde Callihan, Catherine E Monahan, et al.Environmental Research|May 6, 2023
Exposure to volatile hydrocarbons and neurologic function among oil spill workers up to 6 years after the Deepwater Horizon disasterDazhe Chen, Emily J Werder, Patricia A Stewart, et al.Nature Communications|June 8, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancerZifeng Wang, Scott L Townley, Songqi Zhang, et al.ACS Nano|October 18, 2024
Charge Transfer Plasmonics in Bespoke Graphene/α-RuCl3 CavitiesRocco A Vitalone, Bjarke S Jessen, Ran Jing, et al.Molecular & Cellular Proteomics : MCP|May 8, 2019
Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor MicroenvironmentElizabeth V Nguyen, Brooke A Pereira, Mitchell G Lawrence, et al.Advanced Materials (Deerfield Beach, Fla.)|April 24, 2024
Tunable Phonon Polariton Hybridization in a Van der Waals Hetero-BicrystalLukas Wehmeier, Shang-Jie Yu, Xinzhong Chen, et al.Environmental Health Perspectives|May 24, 2023
Volatile Hydrocarbon Exposures and Incident Coronary Heart Disease Events: Up to Ten Years of Follow-up among Deepwater Horizon Oil Spill WorkersDazhe Chen, Dale P Sandler, Alexander P Keil, et al.Molecular Cancer Therapeutics|August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP InhibitionMitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.Pageof 48